2C-iP
2C-iP, also known as 4-isopropyl-2,5-dimethoxyphenethylamine or as Jelena or Momento, is a psychedelic drug of the phenethylamine and 2C families. It is taken orally. The drug was first described by 2011 and was encountered as a novel designer drug by 2018.Use and effects
2C-iP's dose is 8 to 25mg orally and its duration is 8 to 12hours. It is said that careful dose titration is necessary to avoid overdose. The drug is said to produce a strong sense of heightened awareness of the present moment, resulting in the nickname "Momento", among other effects.Interactions
Pharmacology
Pharmacodynamics
2C-iP shows affinity for the serotonin 5-HT2 receptors, including for the serotonin 5-HT2A receptor.Chemistry
Analogues
s of 2C-iP include 2C-P, 2C-cP, 2C-iBu, 2C-tBu, 2C-D, 2C-E, 2C-T-4, and DOiP, among others.History
2C-iP was first described in the scientific literature by Dmitri Ger and colleagues by 2011. It was encountered as a novel designer drug in Sweden in 2018.Society and culture
As of October 31, 2016, 2C-iP is a controlled substance in Canada.2C-iP is not an explicitly controlled substance in the United States. However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption. In addition, it may be considered scheduled as an isomer of 2C-P.